Introduction

Spray drying is a cornerstone unit operation in the pharmaceutical industry, particularly for the manufacture of excipients — the inactive ingredients that act as carriers, stabilizers, or modifiers in drug formulations. The technique transforms liquid feed into dry powder in a single, continuous step, enabling precise control over particle properties such as size, morphology, density, and moisture content. For excipients, these characteristics directly influence the performance of solid dosage forms: ensuring uniform blending, improving compression behavior, enhancing dissolution rates, and increasing bioavailability. As drug development shifts toward more complex molecules (e.g., biologics, poorly soluble compounds), the demand for advanced excipients produced via spray drying has grown substantially. This article provides an in-depth look at the technology, its applications, advantages, challenges, quality control strategies, and emerging trends.

Understanding Spray Drying: Process and Principles

Spray drying is a dehydration technique that converts a liquid feed (solution, suspension, or emulsion) into dry particles by exposing atomized droplets to a stream of hot gas, typically air or nitrogen. The process comprises four main stages: atomization, droplet–gas contact, evaporation and particle formation, and powder collection. Each stage can be optimized independently to tailor the final excipient properties.

Atomization

The feed liquid is delivered to an atomizer device inside the drying chamber. Common atomizer types include rotary (wheel) atomizers, pressure nozzles, and pneumatic (two-fluid) nozzles. Rotary atomizers produce a fine, uniform droplet size distribution at high throughputs, while pressure nozzles are preferred for viscous feeds. The choice of atomizer and its operating parameters (e.g., wheel speed, nozzle pressure, feed rate) dictates the initial droplet size, which in turn determines the final particle size. Droplet sizes typically range from 10 to 200 microns.

Droplet–Gas Contact

The atomized spray enters the drying chamber where it meets a co-current, counter-current, or mixed-flow hot gas stream. Co-current flow is most common for heat-sensitive excipients because the droplets are exposed to the highest temperature only momentarily and the product temperature remains low. The gas inlet temperature is set between 120 °C and 250 °C depending on the excipient’s thermal stability. The gas flow rate, humidity, and temperature profile affect the evaporation rate and therefore the particle morphology (e.g., hollow, porous, or solid spheres).

Evaporation and Particle Formation

As the droplets travel through the chamber, solvent (usually water) evaporates rapidly from the surface, causing the droplets to shrink. For solutions, the solute concentration increases until the droplet becomes supersaturated, leading to precipitation and formation of solid particles. For suspensions, the solid particles may assemble into agglomerates. The drying rate influences whether particles are dense or porous: fast drying yields hollow or wrinkled particles, while slower drying produces denser spheres. The outlet temperature (typically 60–100 °C) is a critical parameter; it must be high enough to achieve the desired residual moisture but low enough to avoid degradation.

Powder Collection

The dry particles are separated from the exhaust gas using a cyclone separator, bag filter, or electrostatic precipitator. Cyclones are efficient for coarse powders (>10 µm), while bag filters or high-efficiency cyclones are required for fine excipients (<5 µm). The collected powder is then conveyed to a storage container or further processed (e.g., blended, milled, or coated). Yield rates for spray drying typically exceed 95% with proper equipment design.

For a deeper technical overview, see ScienceDirect’s comprehensive entry on spray drying.

Key Pharmaceutical Excipients Produced via Spray Drying

Spray drying is used to produce a wide range of excipient types. The ability to engineer particle properties makes it the method of choice for performance-critical excipients. Below are the major categories with expanded explanations.

Disintegrants

Superdisintegrants such as crospovidone, crosscarmellose sodium, and sodium starch glycolate are often spray-dried to achieve high porosity and rapid swelling. Spray-dried versions exhibit faster wicking and disintegration times compared to conventional milled grades. For example, spray-dried crospovidone can reduce tablet disintegration time to under 30 seconds while maintaining excellent compressibility.

Fillers and Diluents

Lactose, mannitol, and microcrystalline cellulose (MCC) are common fillers. Spray-dried lactose is widely used for direct compression because the spherical particles flow freely and compress uniformly. Spray-dried mannitol is particularly important for orally disintegrating tablets (ODTs) because it provides a pleasant cooling sensation and high porosity for rapid dissolution.

Binders

Polymer-based binders such as hydroxypropyl cellulose (HPC), polyvinylpyrrolidone (PVP), and hypromellose (HPMC) can be spray-dried to improve their flow properties and reduce dust. Spray-dried binders also facilitate dry granulation processes by providing better distribution of the polymer on the surfaces of other particles.

Coatings and Taste Masking Agents

Spray drying is used to produce encapsulated flavours or coating polymers. Eudragit® polymers and other methacrylate copolymers are spray-dried into fine powders that can be applied as dry coatings or reconstituted for aqueous coating. Taste-masking microcapsules containing bitter APIs can also be produced by co-spray drying with sweeteners or polymer matrices.

Porous Powders for Solubility Enhancement

One of the most valuable applications is the creation of high-porosity powders that increase the surface area available for dissolution. Spray-dried porous silica, such as Syloid® grades, is used as a carrier for liquid self-emulsifying drug delivery systems (SEDDS) or as a directly compressible excipient that improves the dissolution rate of poorly soluble drugs. The porous network can load up to 50% w/w of liquid lipid formulations.

Co-Processed Excipients

Spray drying excels at producing co-processed excipients where two or more functional ingredients (e.g., lactose and MCC) are intimately combined. The resulting particles have synergistic properties that are unattainable with simple physical blends. For instance, Cellactose® (a spray-dried combination of MCC and lactose) offers superior flow and binding capacity for direct compression.

Advantages of Spray Drying for Excipient Manufacturing

Spray drying provides numerous benefits over alternative drying methods (e.g., tray drying, fluid bed drying, freeze drying). These advantages drive its widespread adoption.

Uniform and Controlled Particle Size Distribution

Because droplet size is regulated by atomizer settings, spray drying produces powders with narrow and reproducible particle size distributions. This uniformity ensures consistent flow, packing, and blending behaviour, which is critical for high-speed tablet presses and capsule fillers. For direct compression excipients, a particle size D50 between 150–250 µm is often desired; spray drying can easily achieve that range.

Enhanced Stability of Sensitive Compounds

The process is gentle for heat-labile materials because the solvent evaporation cools the particle surface (evaporative cooling effect). Co-current flow designs keep product temperature low (often below 60 °C) even when inlet gas exceeds 200 °C. This allows drying of thermosensitive excipients like gelatin or certain enzymes without denaturation.

Rapid Drying and High Throughput

Spray drying is a continuous process with short residence times (seconds to minutes). Industrial spray dryers can process hundreds of kilograms of feed per hour, yielding kilograms of powder per hour per unit. This makes it highly efficient for commercial-scale excipient production.

Control Over Moisture Content and Porosity

By adjusting outlet temperature, feed concentration, and flow rates, manufacturers can fine-tune the residual moisture (typically 0.5–5% w/w) and particle porosity. Low moisture content improves chemical stability and prevents caking during storage. High porosity (pore volumes up to 2.5 mL/g) enhances dissolution by increasing the surface area available for wetting.

Direct Compression Capability

Spray-dried particles are often spherical with smooth surfaces, granting excellent flowability and compressibility. Tablets made from spray-dried excipients require lower compression forces and produce harder tablets with less variability in weight and hardness. This reduces downtime and rejects in tableting operations.

Encapsulation and Functionalization

Spray drying is a one-step encapsulation technique. Active ingredients (e.g., flavours, probiotics, or APIs) can be embedded in an excipient matrix during drying. This protects them from moisture, heat, or oxidation. It also enables controlled release properties: a spray-dried excipient can be engineered to release its payload only in specific pH environments.

Challenges and Mitigation Strategies

Despite its advantages, spray drying presents challenges that must be carefully managed.

High Initial Equipment Costs

Industrial spray dryers with advanced controls can exceed USD 500,000 – 1 million. Mitigation: Many excipient manufacturers use contract spray drying services or invest in pilot-scale units first to validate the process. Leasing options and custom toll-drying partnerships are also common.

Thermal Degradation of Heat-Sensitive Excipients

Some excipients (e.g., certain polymers or sugar alcohols) can degrade or caramelise at elevated temperatures. Mitigation: Use co-current flow, low inlet temperatures (as low as 100 °C), or inert gas (nitrogen) instead of air to reduce oxidation. Adding a protective excipient (e.g., trehalose) as a stabiliser is another approach.

Stickiness and Hygroscopicity

Excipients with low glass transition temperatures (Tg) may become sticky during drying, causing product build-up on chamber walls or agglomeration. Mitigation: Increase the Tg by incorporating higher-Tg excipients (e.g., adding maltodextrin to sucrose solutions) or by cooling the chamber walls (jacketed walls). Alternatively, use a fluidised bed integrated into the spray dryer (spray drying with fluid bed) to keep particles moving.

Yield Loss of Fine Particles

Very fine particles (<5 µm) may escape the cyclone or bag filter, reducing yield. Mitigation: Optimise atomiser settings to produce coarser droplets (e.g., lower atomisation pressure or larger nozzle orifice). Use high-efficiency cyclones or bag filters designed for submicron collection. Recycle the fines back into the feed.

Residual Solvent Issues

When organic solvents are used (e.g., ethanol, acetone), complete removal must be ensured to comply with ICH Q3C limits. Mitigation: Implement two-stage drying (spray + fluid bed) or use a longer residence time in the chamber. Online monitoring of solvent vapour in the exhaust enables real-time adjustment.

Scale-Up Risks

Process parameters optimised at lab scale (e.g., 1 kg/h) may not directly translate to production scale (100 kg/h). Mitigation: Use dimensionless groups (e.g., Stokes number, drying rate constant) to guide scale-up. Conduct pilot trials at intermediate scale (e.g., 10–50 kg/h) before final scale-up.

Quality Control and Characterization of Spray-Dried Excipients

Excipients produced by spray drying must meet stringent quality specifications. Key properties that require monitoring include particle size distribution (by laser diffraction or sieve analysis), morphology (by scanning electron microscopy), bulk and tapped density, flowability (Hausner ratio, Carr index, or flow through an orifice), moisture content (Karl Fischer or loss on drying), crystallinity (X-ray powder diffraction), and surface area (BET nitrogen adsorption). Additionally, performance tests such as tablet crushing strength, disintegration time, and dissolution are essential for function-specific excipients (e.g., disintegrants, binders).

Process Analytical Technology (PAT) tools such as near-infrared (NIR) spectroscopy and in-line Raman spectroscopy are increasingly used to monitor moisture content and polymorphic form in real time. This enables batch-to-batch consistency and reduces the need for off-line testing. Regulatory guidelines (FDA, ICH Q7A, and ICH Q8) encourage a quality-by-design (QbD) approach, where the design space of critical process parameters (atomiser speed, inlet temperature, feed rate) is defined to ensure robust product quality.

For a detailed discussion on excipient quality control, refer to FDA guidelines on excipient testing.

Recent Innovations and Future Directions

The field of spray-dried excipients continues to evolve with new technologies and applications.

Nano-Spray Drying

Miniaturised spray dryers with vibrating mesh atomisers can produce submicron particles (<1 µm). This enables the creation of excipient nanoparticles for targeted drug delivery or for improving the bioavailability of poorly soluble compounds. Excipients such as spray-dried mannitol nanoparticles are being explored as carriers for pulmonary delivered drugs.

Spray Drying in Continuous Manufacturing

With the push toward continuous pharmaceutical production (e.g., via continuous direct compression or twin-screw granulation), spray drying is being integrated as a continuous powder manufacturing step. Real-time material tracking and feedback control loops ensure that excipient properties remain stable, even when upstream conditions fluctuate.

Tailored Encapsulation for Biologics

Biologics (e.g., peptides, monoclonal antibodies) require excipients that maintain activity during drying and storage. Advances in spray-dried amorphous solid dispersions (ASDs) with excipients like HPMCAS or Eudragit® enable high drug loading (up to 40% w/w) while preserving the protein’s structure. Co-spray drying with trehalose and leucine has been shown to stabilise vaccines for ambient-temperature storage.

Green Solvent and Energy Reduction

To reduce environmental impact, manufacturers are exploring water-based feeds (eliminating organic solvents), lower inlet temperatures, and heat recovery systems. Some new spray dryers use electric heating powered by renewable sources. Additionally, supercritical CO₂-assisted spray drying (e.g., the Particle Engineering by Gas Saturated Solutions (PGSS™) process) operates at lower temperatures, further cutting energy use.

Smart Excipients with Responsive Properties

Spray drying enables the incorporation of stimuli-responsive polymers (pH-, temperature-, or glucose-responsive) into excipients. These “smart” excipients can trigger drug release at specific sites in the gastrointestinal tract, which is especially valuable for targeting colonic drug delivery or treating inflammation.

A recent review summarising technical advances can be found at Pharmaceutics journal (2020): Spray Drying as a Tool for Controlled Particle Engineering.

Conclusion

Spray drying is an indispensable technology for manufacturing high-performance pharmaceutical excipients. Its ability to produce powders with uniform particle size, tailored porosity, enhanced flowability, and excellent stability makes it the preferred choice for direct compression, ODT formulations, solubility enhancement, and taste masking. While challenges such as high capital costs, thermal sensitivity, and scale-up complexities exist, modern mitigation strategies—including nitrogen inertisation, integrated fluid beds, PAT-driven control, and green process redesign—are making spray drying more accessible and efficient. As the pharmaceutical industry moves toward continuous manufacturing, biologics, and personalised medicines, the role of spray-dried excipients will only expand. Manufacturers who invest in advanced spray drying capabilities and adopt a quality-by-design approach will be well-positioned to deliver excipients that meet increasingly demanding formulation needs. For a market outlook on spray-dried excipients, see Grand View Research’s pharmaceutical excipients market report.